Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Morphic Therapeutic Enters Into Integrin Research and Development Collaboration with Janssen

Friday, February 22, 2019

Morphic Therapeutic Morphic a biotechnology company developing oral integrin therapies announced today that it has entered into a research and development collaboration with Janssen Biotech Inc Janssen to discover and develop novel integrin therapeutics for patients with conditions not adequately ad..

Torque Announces Clinical Trial Collaboration with Merck

Friday, February 22, 2019

Torque a clinicalstage immunooncology company developing firstinclass Deep Primed T Cell Therapeutics to direct immune power deep within the tumor microenvironment announced today that it has entered into a clinical trial collaboration agreement with Merck known as MSD outside of the US and Canada T..

Adial Pharmaceuticals Announces Partnership with Catalent to Package and Distribute Adial’s AD04 for its Phase 3 Trial

Thursday, February 21, 2019

Adial Pharmaceuticals Inc wwwadialpharmacom a clinicalstage biopharmaceutical company focused on the development of medicines for addiction today announced a partnership with Catalent Pharma Solutions a leading global provider of advanced delivery technologies and development solutions for drugs bio..

NanoSphere Signs Definitive Licensing Agreement in Oregon

Thursday, February 21, 2019

NanoSphere Health Sciences Inc is pleased to announce the signing of a definitive Licensing Agreement with Oregon cannabis company Cascade Pure LLC The Agreement gives Cascade Pure the exclusive right to produce and distribute Evolve Formulas products in the State of Oregon NanoSphere Health Scie..

Aucta Pharmaceuticals and Oakrum Pharma Announce Product Development and Commercial Cooperation

Wednesday, February 20, 2019

Aucta Pharmaceuticals Inc Aucta announced today that it has entered into an agreement with Oakrum Pharma LLC Oakrum to develop and produce four A prescription generic product intended to be commercialized in the United States under the Oakrum trademark These products are expected to serve the re..

Exicure Announces License and Development Agreement with Dermelix Biotherapeutics in Rare Genetic Skin Diseases

Wednesday, February 20, 2019

Exicure Inc OTCQB XCUR the pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid SNA constructs and Dermelix Biotherapeutics a biopharmaceutical company focused on the development of innovative treatments for rare genetic skin diseases today announced a license and ..

QIAGEN partners with Ares Genetics to advance global fight against antibiotic-resistant pathogens

Tuesday, February 19, 2019

QIAGEN NV today announced a broad agreement with Ares Genetics a subsidiary of Curetis NV to develop innovative bioinformatics and assay solutions to accelerate research targeting the growing global health challenges posed by antibioticresistant bacteria QIAGEN has acquired an exclusive license t..

WuXi STA and BioLingus sign exclusive technology and marketing collaboration for sublingual delivery

Tuesday, February 19, 2019

STA Pharmaceutical Co Ltd WuXi STA a subsidiary of WuXi AppTec and BioLingus a Swiss biotech company announce they have formed an exclusive technology and marketing collaboration for sublingual delivery Under the terms of the collaboration WuXi STA will have exclusive access to BioLingus technolo..

Innovent Announces a Collaboration with Chipscreen Biosciences to Evaluate the Combination Therapy in Colorectal Cancer Patients

Monday, February 18, 2019

Innovent Biologics Inc a worldclass biopharmaceutical company that develops manufactures and commercializes high quality innovative medicines for the treatment of oncology autoimmune and other major diseases today announced the signing of a collaboration agreement with Shenzhen Chipscreen Bioscience..

Decipher Biosciences Announces Research Collaboration with Dendreon to Identify Genomic Drivers of Patient Response to Sipuleucel-T

Saturday, February 16, 2019

Decipher Biosciences a leader in the field of urologic cancer genomics today announced a research collaboration with Dendreon Pharmaceuticals a commercialstage biopharmaceutical company and pioneer in the development of immunotherapy to apply genomic tumor profiling using the Decipher assay and GRID..